The Use of Antiviral Drugs for Influenza: Recommended Guidelines for Practitioners by Upton D Allen, Fred Y Aoki, H Grant Stiver, for the Canadian Paediatric Society and the Association of Medical Microbiology and Infectious Disease Canada

“…The present document outlines current guidelines and supporting literature relating to the use of antiviral drugs for chemoprophylaxis and influenza illness therapy in paediatric and adult settings. …”
Get full text

The Use of Antiviral Drugs for Influenza: A Foundation Document for Practitioners by Fred Y Aoki, Upton D Allen, H Grant Stiver, Michel Laverdière, Gerald A Evans

Get full text

Antiviral Drugs and Vaccines for Omicron Variant: A Focused Review by Nidhi Garg, Ananya Sree Kunamneni, Pankaj Garg, Sandeep Sharma, Divakar Sharma, Adinarayana Kunamneni

“…Drugs that are effective against the Omicron variant are oral antiviral drugs such as Paxlovid (nirmatrelvir/ritonavir), remdesivir, sotrovimab, and molnupiravir. …”
Get full text

Estimation of Some Antiviral Drugs Using Tpooo as Analytical Reagent by P. Venkata Reddy, B. Sudha Rani

“…A simple and reproducible spectrophotometric method has been developed for the determination of two recent antiviral drugs namely Valacyclovir (drug A) and Famciclovir (drug B) in bulk and pharmaceutical dosage forms. …”
Get full text

Guidance on The Use of Antiviral Drugs for Influenza in Acute Care Facilities in Canada, 2014-2015 by H Grant Stiver, Gerald A Evans, Fred Y Aoki, Upton D Allen, Michel Laverdière

Get full text

Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study by Asiye Aslı Emniyet Sert, Cemile Merve Seymen, Gülnur Take Kaplanoğlu

“…TNF-α, IL-1β, and IL-6 immunoreactivities were found to be significantly higher in the antiviral drug-administered groups than in the sham control groups. …”
Get full text

RETRACTED: Experimental use of the antiviral drug "Triazavirin" for the treatment of calves with symptoms of respiratory system damage by Reshetnikova Tatiana, Kuzmin Vladimir, Krylova Tatyana

Get full text

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance by Mark A. Wainberg

Get full text

Retracted: Topological Coindices and Quantitative Structure-Property Analysis of Antiviral Drugs Investigated in the Treatment of COVID-19 by Journal of Chemistry

Get full text

QSPR/QSAR study of antiviral drugs modeled as multigraphs by using TI’s and MLR method to treat COVID-19 disease by Ugasini Preetha P, M. Suresh, Fikadu Tesgera Tolasa, Ebenezer Bonyah

Subjects: “…Antiviral drugs…”
Get full text

Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery by Francisco Javier Hermoso-Pinilla, Aitor Valdivia, María-José Camarasa, Tiziana Ginex, Francisco Javier Luque

Get full text

Repurposing antiviral drugs targeting the PARP-1 and HER2 pathways with multifaceted impacts through integrated network analysis and molecular mechanics by Uma Maheshwari Mugundan, Praveen Sekar, Rajanandh Muhasaparur Ganesan

“…This study investigates the anticancer potential of existing anti-viral drugs using a comprehensive suite of computational methods. A dataset of 76 antiviral drugs was prepared and optimized for analysis. …”
Get full text

Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability by Sri Rekha M., Sangeetha S.

Get full text

Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis by Sarah R. Donaldson, Andrew Radley, John F. Dillon

Get full text

Contemporary Antiviral Drug Regimens for the Prevention and Treatment of Orolabial and Anogenital Herpes Simplex Virus Infection in the Normal Host: Four Approved Indications and 13 Off-Label Uses by Fred Y Aoki

Get full text

In-silico screening and analysis of missense SNPs in human CYP3A4/5 affecting drug-enzyme interactions of FDA-approved COVID-19 antiviral drugs by Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, Sameh E. Hassanein

“…Molecular docking was done to recognize the structural stability and binding properties of the CYP3A4/5 protein isoforms with 3 FDA-approved antiviral drugs. Our findings indicated that the CYP3A4 gene variants; R418T, I335T and R130P and the CYP3A5 gene variants; I335T, L133P and R130Q are considered the most deleterious missense SNPs. …”
Get full text

Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M^pro by Jiayi Ren, Zhengfu Zhang, Yi Xia, Daqun Zhao, Dingqin Li, Shujun Zhang

Subjects: Get full text

Overview of Recent Advances in Canine Parvovirus Research: Current Status and Future Perspectives by Hongzhuan Zhou, Kaidi Cui, Xia Su, Huanhuan Zhang, Bing Xiao, Songping Li, Bing Yang

Subjects: Get full text

Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical... by Jiangtao Bai, Tetsuya Asakawa, Wenfang Yuan, Yuanlong Lin, Hao Ju, Dandan Xu, Mingming Yang, Shuo Li, Guanguan Li, Deyin Guo, Hongzhou Lu, Xumu Zhang

Subjects: “…Oral small molecular antiviral drug…”
Get full text

SARS-CoV-2 drug resistance and therapeutic approaches by Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, Yun Hee Baek, Min-Suk Song

Subjects: “…Antiviral drugs…”
Get full text